Löfdahl, A.; Tornling, G.; Wigén, J.; Larsson-Callerfelt, A.-K.; Wenglén, C.; Westergren-Thorsson, G.
Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. Int. J. Mol. Sci. 2021, 22, 225.
https://doi.org/10.3390/ijms22010225
AMA Style
Löfdahl A, Tornling G, Wigén J, Larsson-Callerfelt A-K, Wenglén C, Westergren-Thorsson G.
Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. International Journal of Molecular Sciences. 2021; 22(1):225.
https://doi.org/10.3390/ijms22010225
Chicago/Turabian Style
Löfdahl, Anna, Göran Tornling, Jenny Wigén, Anna-Karin Larsson-Callerfelt, Christina Wenglén, and Gunilla Westergren-Thorsson.
2021. "Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases" International Journal of Molecular Sciences 22, no. 1: 225.
https://doi.org/10.3390/ijms22010225
APA Style
Löfdahl, A., Tornling, G., Wigén, J., Larsson-Callerfelt, A.-K., Wenglén, C., & Westergren-Thorsson, G.
(2021). Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. International Journal of Molecular Sciences, 22(1), 225.
https://doi.org/10.3390/ijms22010225